The impact of METTL3 on bladder cancer through m6A modification: a potential therapeutic target and prognostic biomarker
Bladder cancer (BCa) is one of the most prevalent malignant tumors globally, particularly among men. According to data from the Global Cancer Research Agency, the annual incidence of BCa continues to rise, and its clinical features are complex, involving various molecular mechanisms and pathophysiol...
Saved in:
| Main Authors: | Dong Wen, Pengcheng Fu, Geliu Shuai, Yuebin Wang, Shengxin Yu, Huiquan Liu, Wei Wan, Junrong Zou, Xiaofeng Zou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1622117/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MSH6 as a prognostic biomarker in bladder cancer and its correlation with immunity
by: Ning He, et al.
Published: (2025-07-01) -
Unraveling the dual role of METTL3-mediated m6A RNA modification in bladder cancer: mechanisms, therapeutic vulnerabilities, and clinical implications
by: Hua Chun, et al.
Published: (2025-12-01) -
Cathepsin B in urological tumors: unraveling its role and therapeutic potential
by: Zhaojie Yan, et al.
Published: (2025-05-01) -
Prognostic markers of urinary bladder cancer lymphatic spread
by: V. N. Pavlov, et al.
Published: (2012-04-01) -
Integrated prognostic assessment of apoptosis and chemotherapy related gene in bladder cancer: a prognostic signature
by: Keyuan Zhao, et al.
Published: (2025-05-01)